Validez y confiabilidad del Inventario de orientación suicida ­ ISO-30 en una población colombiana / Validación de la escala de orientación al suicidio ISO-30 / Validity and reliability of the Inventory of suicide orientation ­ ISO-30 in a colombian population

El presente estudio instrumental evaluó las propiedades psicométricas del Inventario de Orientación Suicida ­ ISO-30 con 1922 adolescentes escolarizados de la ciudad de Bogotá. La validez de constructo del inventario se estableció a través de un análisis factorial confirmatorio, utilizándose el método de mínimos cuadrados generalizados (GLS), dando lugar un modelo factorial sustentable, compuesto por cinco factores, igual al inventario original. La confiabilidad del instrumento se estableció, a través del coeficiente Alfa de Cronbach, obteniéndose una confiabilidad excelente (α= .0915) y un coeficiente Omega (Ω=.742). El análisis de reactivos relativo al poder de discriminación del inventario obtuvo un 57% en las correlaciones ítem-escala total con un nivel de discriminación excelente. Se presenta evidencia respecto a la validez y confiabilidad del ISO-30 para evaluar la orientación al suicidio en adolescentes colombianos

The present instrumental study evaluated the psychometric properties of the Inventory of Suicide Orientation - ISO-30 with 1922 school adolescents from Bogotá. The construct validity of the inventory was established through confirmatory factor analysis, using the generalized least squares (GLS) technique, through which a sustainable factorial model was obtained, composed of five factors equal to the original inventory. The reliability of the instrument was established using Cronbach's Alpha coefficient with an excellent result (α= .915) and an omega coefficient (Ω=.742). The analysis of the items, relative to the discrimination power of the items, obtained 57% in item-total scale correlations with an excellent level of discrimination power. These findings prove ISO-30 to be a valid and reliable instrument for evaluating suicide orientation among Colombian adolescents.

Prevalence of lymph node involvement in patients with endometrial cancer, Colombia 2009-2016: Exploratory analysis of associated factors / Prevalencia del compromiso ganglionar en pacientes con cáncer de endometrio, colombia 2009-2016: análisis exploratorio de factores asociados

RESUMEN Objetivo: determinar la prevalencia del compro miso ganglionar de pacientes con cáncer de endometrio y hacer una exploración de los factores asociados a la invasión ganglionar. Materiales y métodos: estudio de prevalencia con análisis exploratorio. Se incluyeron pacientes con cáncer de endometrio llevadas a histerectomía abdominal total más salpingooforectomía bilateral y linfadenectomía pélvica, con o sin linfadenectomía paraaórtica en siete centros de oncología de Colombia, en el periodo 2009-2016. Se excluyeron pacientes con radioterapia o quimioterapia previa, diagnóstico histológico de tumores neuroendocrinos, carcinosarcomas, tumores sincrónicos o metacrónicos. Muestreo no probabilístico. Tamaño muestral n = 290. Variables medidas: sociodemográficas, clínicas e histopatológicas y compromiso ganglionar pélvico o paraaórtico. Se presenta la prevalencia de periodo; el análisis exploratorio se realizó por medio de odds ratio (OR) crudo y el ajustado mediante un modelo multivariado (regresión logística no condicional). Resultados: se obtuvieron 467 casos de los cuales se excluyeron 163 por no presentar la totalidad de las variables, se estudiaron 304 pacientes. La prevalencia del compromiso ganglionar fue del 15,8 % (48/304). Los factores asociados al compromiso ganglionar en el análisis crudo y ajustado fueron la invasión linfovascular (OR ajustado = 9,32; IC 95 %: 4,27-21,15) e invasión miometrial (OR ajustado = 3.95; IC 95 %: 1,29-14,98). Conclusión: el 15 % de las pacientes sometidas a linfadenectomía tienen compromiso ganglionar. Se deben evaluar alternativas diagnósticas menos invasivas que la cirugía radical para establecer la invasión ganglionar.

ABSTRACT Objective: To determine the prevalence of lymph node involvement in patients with endometrial cancer and to explore factors associated with lymph node invasion. Materials and methods: Prevalence study with exploratory analysis. The study included patients with endometrial cancer who underwent total abdominal hysterectomy plus bilateral salpyingooophorectomy and pelvic lymphadenectomy with or without para-aortic lymphadenectomy in seven oncology centers in Colombia between 2009 and 2016. Patients who had received prior radiotherapy or chemotherapy, with a histological diagnosis of neuroendocrine tumors, carcinosarcomas or synchronous or metachronous lesions were excluded. Non-probabilistic sampling. Sample size n=290. Measured variables: sociodemographic, clinical and histopathological, and pelvic or para-aortic lymph node involvement. The prevalence for the period is presented. The exploratory analysis was conducted using crude odds ratio (OR) and adjusted OR by means of a multivariate model (unconditional logistic regression). Results: Overall, 467 cases were retrieved. Of them, 163 were excluded because of non-availability of all the variables. In total, 304 patients were studied. The prevalence of lymph node involvement was 15.8 % (48/304). In the crude and adjusted analysis, factors associated with lymph node involvement were lymphovascular invasion (adjusted OR: 9.32; 95 % CI 4.27-21.15) and myometrial invasion (adjusted OR: 3.95; 95 % CI 1.29-14.98). Conclusion: Of the patients undergoing lymphadenectomy, 15 % have lymph node involvement. Less invasive diagnostic options than radical surgery to ascertain lymph node invasion should be assessed.

Enfermedades crónicas no transmisibles prioritarias en la Región Caribe Colombiana en el periodo 2008-2015: un análisis de la mortalidad / Chronic noncommunicable diseases priority in the Colombian Caribbean Region in the period 2008-2015: An analysis of mortality

RESUMEN Objetivo: Estimar el riesgo de muerte por enfermedades crónicas no transmisibles prioritarias en la región Caribe colombiana en el periodo 2008-2015. Materiales y métodos: Mediante un estudio ecológico se analizaron los datos de mortalidad disponibles en el Departamento Administrativo Nacional de Estadística (DANE). Con el ajuste de las tasas de mortalidad mediante razones estandarizadas de mortalidad (REM) por edad y sexo y mediante un modelo bayesiano, se estimó el riesgo suavizado de morir por causa de las enfermedades priorizadas. Se valoró su evolución temporal con tasas ajustadas anuales de mortalidad. Resultados: De 2008 a 2015 ocurrieron 148.331 muertes, de las cuales 76 201 (51,4 %) ocurrieron en hombres. El 58.1 % (86 185 muertes) corresponden a trastornos en el sistema circulatorio, seguido de los tumores malignos con un 24.4 % (36 188 muertes). Las enfermedades isquémicas del corazón ocupan el primer lugar en las causas de muerte, con un aumento significativo (p<0,001) del riesgo a partir de 2011, al igual que la tendencia en neoplasias de próstata (p<0,001) y mama en mujeres (p=0,022). Conclusión: La mortalidad debida a las enfermedades crónicas no transmisibles estudiadas aumentó en la región en el período 2008-2015. Con una mayor tendencia en el riesgo en los hombres para la mayoría de las enfermedades, lo que genera información relevante para que los tomadores de decisiones en salud ajusten los programas y servicios de prevención de la enfermedad, promoción, atención y rehabilitación en salud acorde a la realidad del ente territorial.

ABSTRACT Objective: To estimate the risk of mortality due to Chroic noncommunicable diseases priority in the Colombian Caribbean region using Bayesian methods for the 2008-2015 period. Instruments and methods: Through an ecological study, the mortality data available in the National Administrative Department of Statistics (DANE) database was analyzed. Adjusting the mortality rates using standardized mortality ratios (REM) by age and gender and using a Bayesian model, the smoothed risk of dying due to prioritized diseases was estimated. Its temporal evolution was assessed with annual adjusted mortality rates. Results: For the 2008 - 2015 period, 148,331 people died, 76 201 (51.4 %) of which were men. 58.1 % (86 185 deaths) correspond to disorders in the circulatory system, followed by malignant tumors with 24.4 % (36 188 deaths). Ischemic heart diseases occupy the first place in the causes of death with a significant increase (p<0,001) of risk as of 2011, likewise for prostate neoplasms (p<0,001) and breast neoplasms in women (p=0,022). Conclusion: Mortality due to the observed chronic noncommunicable diseases increased in the region during the 2008-2015 period. There is a greater tendency of risk for men for the majority of the diseases which generates relevant information so that the decisión makers in healthcare adjust the programs and services of disease prevention, promotion, attention and rehabilitation according to the reality of the territorial entity.

Diabetes gestacional: implementación de una guía para su detección en la atención primaria de salud / Implementation of a clinical guideline for detection of gestational diabetes in primary care

Background: Gestational diabetes (GD) impacts maternal and fetal morbidity. In 2012, the World Diabetes Foundation provided financing project in Barranquilla (Colombia), aimed to implement a clinical guide for the diagnosis and treatment of this condition. Aim: To estimate the adherence of the guide in primary care centers. Material and Methods: A Cross-sectional study of pregnant women suspected of having gestational diabetes. Pregnant women were classified according to the week of admission to the prenatal control program: < week 24 or later. Women with a fasting blood glucose over 92 mg/dL and under 126 mg/dL or with some positive result to the oral glucose tolerance test were included. Results: Nine percent (1,887 women) of 21,699 registries of pregnant women, were at risk for gestational diabetes. Of these, 1,880 registries with complete data were analyzed. Sixty nine entered the program at less than 24 weeks of pregnancy and 71% had had a fasting blood glucose measured in the first control. In 69.2% of these women, criteria for gestational diabetes was met. A glucose tolerance test was suggested to women with a blood glucose below 92 mg/dl. Among 72% of the latter, the glucose tolerance test met the criteria for gestational diabetes. Among the 498 women who entered the program after 24 weeks of gestation, 68% met the criteria for gestational diabetes with the fasting blood glucose levels. In 90 women, a glucose tolerance test was performed and 80% met the criteria for gestational diabetes. Conclusions: An adequate adherence to guidelines favors the detection of pregnant women with gestational diabetes.